Dt&C Co., Ltd. (KOSDAQ:187220)
2,400.00
-20.00 (-0.83%)
At close: Feb 2, 2026
Dt&C Co., Ltd. Revenue
Dt&C Co., Ltd. had revenue of 32.63B KRW in the quarter ending September 30, 2025, with 15.33% growth. This brings the company's revenue in the last twelve months to 121.78B, up 19.81% year-over-year. In the year 2024, Dt&C Co., Ltd. had annual revenue of 111.94B with 15.71% growth.
Revenue (ttm)
121.78B
Revenue Growth
+19.81%
P/S Ratio
0.23
Revenue / Employee
441.23M
Employees
276
Market Cap
27.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 111.94B | 15.20B | 15.71% |
| Dec 31, 2023 | 96.74B | -13.80B | -12.48% |
| Dec 31, 2022 | 110.54B | 12.74B | 13.03% |
| Dec 31, 2021 | 97.79B | 13.35B | 15.81% |
| Dec 31, 2020 | 84.44B | 10.65B | 14.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PC Direct | 360.51B |
| Hanil Chemical Ind. | 126.90B |
| Saltware | 61.95B |
| ChoA Pharmaceutical Co., LTD. | 60.50B |
| Softcen | 56.35B |
| Seosan | 41.21B |
| Zinitix | 40.35B |
| Atum Co.,Ltd | 38.61B |